Elevai Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	3.33	1.15	0.41
Cash & Cash Equivalents	3.33	1.15	0.41
Cash Growth	188.06%	180.41%	-
Receivables	0.04	0.01	0
Inventory	0.5	0.23	0.16
Other Current Assets	1.06	0.15	0.06
Total Current Assets	4.92	1.55	0.64
Property, Plant & Equipment	0.26	0.33	0.03
Other Long-Term Assets	0.01	0.01	0
Total Long-Term Assets	0.27	0.34	0.03
Total Assets	5.19	1.89	0.67
Accounts Payable	0.75	0.4	0.22
Current Debt	0.15	0.11	0
Other Current Liabilities	0.41	0.08	0
Total Current Liabilities	1.3	0.59	0.22
Long-Term Debt	0.07	0.17	0
Total Long-Term Liabilities	0.07	0.17	0
Total Liabilities	1.36	0.76	0.22
Total Debt	0.21	0.28	0
Debt Growth	-25.68%	-	-
Retained Earnings	-7.02	-2.72	-0.92
Comprehensive Income	0	0	0
Shareholders' Equity	3.83	1.13	0.45
Net Cash / Debt	3.12	0.87	0.41
Net Cash / Debt Growth	257.51%	111.65%	-
Net Cash Per Share	0.29	0.09	0.04
Working Capital	3.62	0.96	0.42
Book Value Per Share	0.36	0.12	0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).